SOURCE: BIOLASE Technology, Inc.

BIOLASE Technology, Inc.

October 27, 2009 06:00 ET

BIOLASE to Present at the AeA Classic Financial Conference in San Diego, CA

IRVINE, CA--(Marketwire - October 27, 2009) - BIOLASE Technology, Inc. (NASDAQ: BLTI), the world's leading dental laser company, announced today that CEO David M. Mulder and CFO Brett L. Scott are scheduled to make a series of investor presentations at the AeA Classic Financial Conference on Tuesday, November 3. The conference is being held November 1-3, at the San Diego Marriott Hotel & Marina in San Diego, CA.

"We are pleased to be presenting at this prestigious AeA conference, which provides exclusive access to more than 300 technology-focused investors," said Mulder. "This is a terrific opportunity for us to communicate BIOLASE's progress and vision, and to expand our audience within the investment community, particularly with those based on the West coast."

About AeA

AeA (formerly the American Electronics Association), founded in 1943, is a nationwide non-profit trade association that represents all segments of the technology industry and is dedicated solely to helping its members' top line and bottom line. The AeA does this in partnership with its small, medium, and large member companies by lobbying governments at the state, federal, and international levels; providing access to capital and business opportunities; and offering select business services and networking programs.

About BIOLASE Technology, Inc.

BIOLASE Technology, Inc. (, the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.

Contact Information

  • For further information, please contact:
    Jill Bertotti
    Allen & Caron